The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis-Reference-Cited by-同舟云学术

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

Published:2023-01 Issue:1 Volume:13 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical & Translational All

Author:

Spekhorst Lotte S.¹,de Graaf Marlies¹,van der Rijst Lisa P.¹^ORCID,Zuithoff Nicolaas P. A.²,Schweizer René C.³,Kamsteeg Marijke⁴,Haeck Inge⁵,van Lynden‐van Nes Anneke M. T.⁶,van Lumig Paula⁷,Romeijn Geertruida L. E.⁸,Schuttelaar Marie‐Louise⁸,de Bruin‐Weller Marjolein S.¹

Affiliation:

1. Department of Dermatology and Allergology National Expertise Center for Atopic Dermatitis University Medical Center Utrecht Utrecht The Netherlands

2. Julius Center for Health Sciences and Primary Care University Medical Center Utrecht Utrecht The Netherlands

3. Department of Pulmonology University Medical Center Utrecht Utrecht The Netherlands

4. Department of Dermatology Radboud University Medical Center Nijmegen The Netherlands

5. Department of Dermatology Reinier de Graaf Gasthuis Delft The Netherlands

6. Department of Dermatology Meander Medisch Centrum Amersfoort The Netherlands

7. Department of Dermatology University Medical Center Maastricht Maastricht The Netherlands

8. Department of Dermatology University Medical Center Groningen Groningen The Netherlands

Funder

Regeneron Pharmaceuticals

AbbVie

Sanofi

LEO Pharma

Eli Lilly and Company

Pfizer

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clt2.12219

Reference7 articles.

1. Mechanisms of Dupilumab

2. Global Initiative for Asthma.Difficult‐to‐Treat and Severe Asthma in Adolescent and Adult Patients: Diagnosis and Management. A GINA Pocket Guide for Health Professionals. Version 3.

3. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

4. Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dupilumab on asthma and aeroallergen sensitization in pediatric atopic dermatitis patients: Results of the BioDay registry;Pediatric Allergy and Immunology;2024-06

2. Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective;British Journal of Dermatology;2024-02-29

3. Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study;Journal of the European Academy of Dermatology and Venereology;2024-02-08

4. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma;American Journal of Respiratory and Critical Care Medicine;2024-02-01

5. Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps;Journal of Dermatological Treatment;2023-09-04